Glenmede Trust’s Accenture ACN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$84.1M Sell
423,979
-25,394
-6% -$5.92M 0.41% 53
2025
Q4
$121M Buy
+449,373
New +$114M 0.57% 37
2025
Q1
$139M Sell
444,526
-10,830
-2% -$3.82M 0.74% 27
2024
Q4
$160M Sell
455,356
-75,410
-14% -$27.1M 0.82% 19
2024
Q3
$188M Sell
530,766
-7,636
-1% -$2.51M 0.9% 17
2024
Q2
$163M Sell
538,402
-20,327
-4% -$6.23M 0.83% 20
2024
Q1
$194M Sell
558,729
-36,293
-6% -$13.2M 0.97% 15
2023
Q4
$209M Sell
595,022
-53,112
-8% -$17.1M 1.08% 12
2023
Q3
$199M Buy
648,134
+666
+0.1% +$210K 1.14% 11
2023
Q2
$185M Hold
647,468
1.05% 11
2023
Q1
$185M Buy
647,468
+200,130
+45% +$54.6M 1.05% 11
2022
Q4
$119M Buy
447,338
+3,489
+0.8% +$965K 0.7% 26
2022
Q3
$114M Sell
443,849
-3,048
-0.7% -$881K 0.72% 26
2022
Q2
$124M Sell
446,897
-176,458
-28% -$53M 0.73% 24
2022
Q1
$210M Buy
623,355
+40,699
+7% +$13.7M 1.03% 9
2021
Q4
$242M Sell
582,656
-8,384
-1% -$3.06M 1.15% 10
2021
Q3
$189M Sell
591,040
-15,565
-3% -$5.06M 0.98% 13
2021
Q2
$179M Sell
606,605
-10,126
-2% -$2.9M 0.92% 15
2021
Q1
$170M Buy
616,731
+47,124
+8% +$12.2M 0.92% 16
2020
Q4
$149M Sell
569,607
-40,863
-7% -$9.8M 0.82% 18
2020
Q3
$138M Sell
610,470
-21,364
-3% -$4.89M 0.83% 19
2020
Q2
$136M Sell
631,834
-601,337
-49% -$114M 0.83% 18
2020
Q1
$260M Hold
1,233,171
1.18% 4
2019
Q4
$260M Sell
1,233,171
-18,181
-1% -$3.54M 1.18% 4
2019
Q3
$241K Sell
1,251,352
-3,175
-0.3% -$614K 1.1% 7
2019
Q2
$232K Buy
1,254,527
+40,882
+3% +$7.34M 1.02% 7
2019
Q1
$214K Buy
1,213,645
+476,690
+65% +$74.9M 0.97% 7
2018
Q4
$104K Buy
736,955
+29,640
+4% +$4.69M 0.51% 45
2018
Q3
$120M Sell
707,315
-709,763
-50% -$118M 0.48% 38
2018
Q2
$232M Buy
1,417,078
+24,654
+2% +$3.83M 1.03% 6
2018
Q1
$213M Hold
1,392,424
0.89% 7
2017
Q4
$213M Sell
1,392,424
-8,824
-0.6% -$1.28M 0.89% 7
2017
Q3
$189M Sell
1,401,248
-20,166
-1% -$2.63M 0.83% 10
2017
Q2
$170M Hold
1,421,414
0.81% 8
2017
Q1
$170M Buy
1,421,414
+108,507
+8% +$13M 0.81% 8
2016
Q4
$154M Sell
1,312,907
-48,374
-4% -$5.74M 0.84% 9
2016
Q3
$166M Buy
1,361,281
+61,322
+5% +$6.98M 0.94% 8
2016
Q2
$147M Buy
1,299,959
+28,963
+2% +$3.36M 0.89% 9
2016
Q1
$147M Buy
1,270,996
+25,793
+2% +$2.65M 0.95% 9
2015
Q4
$130M Buy
1,245,203
+6,615
+0.5% +$698K 0.89% 7
2015
Q3
$122M Buy
1,238,588
+232,344
+23% +$23.1M 0.89% 8
2015
Q2
$97.4M Sell
1,006,244
-137,168
-12% -$13.1M 0.7% 14
2015
Q1
$107M Buy
1,143,412
+460,883
+68% +$41.1M 0.78% 11
2014
Q4
$61M Sell
682,529
-192,001
-22% -$15.9M 0.48% 36
2014
Q3
$71.1M Buy
874,530
+125,976
+17% +$10.1M 0.62% 25
2014
Q2
$60.5M Sell
748,554
-61,928
-8% -$4.97M 0.54% 34
2014
Q1
$64.6M Buy
810,482
+155,965
+24% +$12.8M 0.6% 34
2013
Q4
$53.8M Buy
654,517
+18,284
+3% +$1.38M 0.55% 40
2013
Q3
$46.9M Sell
636,233
-13,645
-2% -$1.01M 0.56% 42
2013
Q2
$46.8M Buy
+649,878
New +$51.6M 0.58% 40

Other funds holding ACN

Glenmede Trust's ACN Position: Q1 2026 in Review

Glenmede Trust reduced its Accenture (ACN) stake by 5.7% in Q1 2026, selling an estimated $5.92M and leaving 423,979 shares worth $84.1M. The position accounts for 0.41% of the portfolio, ranked #53.

Glenmede Trust first reported a position in ACN in Q2 2013 and has held it in 50 quarters since. The position peaked at $260M in Q1 2020. 2,149 funds tracked by Wall St. Rank hold ACN as of Q1 2026.

  • Glenmede Trust held 423,979 shares of Accenture worth $84.1M as of Q1 2026.
  • Glenmede Trust sold 25,394 Accenture shares in Q1 2026, an estimated $5.92M.
  • Accenture made up 0.41% of Glenmede Trust's portfolio in Q1 2026, its #53 holding.
  • Glenmede Trust first reported a position in Accenture in Q2 2013 and has held it in 50 quarters since.
  • Glenmede Trust's Accenture position peaked at $260M in Q1 2020.
  • 2,149 funds tracked by Wall St. Rank held Accenture as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.